JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 37 No. 9 1444-1448
© 1996 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohtomo, K.
Right arrow Articles by Fukuma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtomo, K.
Right arrow Articles by Fukuma, H.

Thallium-201 Scintigraphy to Assess Effect of Chemotherapy in Osteosarcoma

Katsuyuki Ohtomo , Shoji Terui , Ryohei Yokoyama, Hiroyuki Abe, Takashi Terauchi, Go Maeda, Yasuo Beppu and Hisatoshi Fukuma

Divisions of Nuclear Medicine and Orthopedic Surgery, National Cancer Center Hospital, Tokyo, Japan
Adviser for Bone Tumor Pathology in the Committee of Musculoskeletal Tumor, Japanese Orthopaedic Association, Tokyo, Japan

Correspondence: For correspondence contact: Shoji Terui, MD, Division of Nuclear Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan.

Correspondence: For reprints contact: Katsuyiki Ohtomo, MD, Department of Orthopedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.

ABSTRACT

Imaging results in patients with high-grade osteosarcoma of the extremities were reviewed to determine whether scintigraphic appearance correlated with histologic response to preoperative chemotherapy. Methods: Histologically, the percent tumor necrosis in specimens from 30 patients were classified into three grades: grade 1 = necrosis less than 60%, grade 2 = 60–89%necrosis and grade 3 = diffuse necrosis greater than 90% based upon whole transverse sections. Scintigraphically, we analyzed 201Tl uptake before and after preoperative chemotherapy. The changes in the tumor-to-background ratio were defined by an alteration ratio. Results: Of the 11 patients with a grade 1 response, the ratio showed –67.1 % ± 45.4% (mean ± s.d.). Of the 9 patients with a grade 2 response, the ratio showed 37.9% ± 29.9% of the 10 patients with a grade 3 response the ratio showed 105.5% ± 12.4%. The ratios correlated well with the histologic grades (p < 0.0001; analysis of variance). Conclusion: Thallium-201 scintigraphy accurately assesses the effect of chemotherapy on osteosarcoma.

Key Words: thallium-201-chloride • osteosarcoma preoperative the chemotherapy




This article has been cited by other articles:


Home page
JCOHome page
F. C. Eilber, G. Rosen, J. Eckardt, C. Forscher, S. D. Nelson, M. Selch, F. Dorey, and F. R. Eilber
Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas
J. Clin. Oncol., July 1, 2001; 19(13): 3203 - 3209.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1996 by the Society of Nuclear Medicine.